Biochemical Evaluation of the Effects of Hydroxyurea in Vitro on Red Blood Cells
Hydroxyurea (HU) is a low-cost, low-toxicity drug that is often used in diseases, such as sickle cell anemia and different types of cancer. Its effects on the red blood cells (RBC) are still not fully understood. The in vitro effects of HU were evaluated on the biochemical parameters of the RBC from...
Main Authors: | Cristiane Oliveira Renó, Grazielle Aparecida Silva Maia, Leilismara Sousa Nogueira, Melina de Barros Pinheiro, Danyelle Romana Alves Rios, Vanessa Faria Cortes, Leandro Augusto de Oliveira Barbosa, Hérica de Lima Santos |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-10-01
|
Series: | Antioxidants |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3921/10/10/1599 |
Similar Items
-
Prevalence and clinical outcomes of polycythemia vera and essential thrombocythemia with hydroxyurea resistance or intolerance
by: Kittitat Chiaranairungrot, et al.
Published: (2022-12-01) -
Hydroxyurea-induced melanonychia
by: Michael G. Buontempo, BS, et al.
Published: (2023-12-01) -
Patients with sickle cell disease taking hydroxyurea in the Hemocentro Regional de Montes Claros
by: Fernanda Kelle de Souza Santos, et al.
Published: (2011-01-01) -
Oral lesions associated with hydroxyurea treatment
by: Regina Mendonça, et al.
Published: (2011-01-01) -
Mutagenicity of hydroxyurea in lymphocytes from patients with sickle cell disease
by: Khayat André Salim, et al.
Published: (2004-01-01)